Alina Rembiszewska - Concepedia

Author

Alina Rembiszewska

The Maria Sklodowska-Curie National Research Institute of Oncology ORCID

Also Known As

A Rembiszewska, A. REMBISZEWSKA, A. Rembiszewska, Alina Rembiszewska

Publications

769

Citations

H-Index

Concepts

All Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology Poznan University of Medical Sciences Polish Academy of Sciences Medical University of Warsaw Szczecin Academy of Arts

About

Alina Rembiszewska is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in medicine, pathology, and ovarian cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	505
2	Cell Biology	5	5	390
3	Public Health	2	2	26
4	Endocrinology	2	2	26
5	Engineering	1	1	44

Alina Rembiszewska

Publications

729

Citations

H-Index

Page 1

	Year	Citations
Ovarian small cell carcinoma of hypercalcemic type – evidence of germline origin and smarca4 gene inactivation. a pilot study Jolanta Kupryjańczyk, Agnieszka Dansonka‐Mieszkowska, Joanna Moes-Sosnowska, Polish Journal of Pathology Immature TeratomaSmarca4 Gene InactivationPathologyGynecologyTumor Biology	2013	115
PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients I Kolasa, Alina Rembiszewska, Anna Felisiak, Cancer Biology & Therapy OncologyPik3ca AmplificationMedicineGynecologyCancer Cell Biology	2009	96
PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations I Kolasa, Alina Rembiszewska, Aneta Janiec–Jankowska, Gynecologic Oncology Brca1 MutationsOncologyCancer PathologyOvarian CarcinomasPten Mutation	2006	82
Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen Jolanta Kupryjańczyk, T Szymańska, Radosław Mądry, British Journal of Cancer	2003	81
HAX-1 overexpression, splicing and cellular localization in tumors Alicja Trębińska, Alina Rembiszewska, Karolina Ciosek, BMC Cancer	2010	69
P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens Joanna Plisiecka-Hałasa, G Karpińska, T Szymańska, Annals of Oncology Platinum-based RegimensOvarian CarcinomasMedicinePathologyCancer Genomics	2003	53
NANOS1 and PUMILIO2 bind microRNA biogenesis factor GEMIN3, within chromatoid body in human germ cells Barbara Ginter-Matuszewska, Kamila Kusz-Zamelczyk, Anna Spik, Histochemistry and Cell Biology Chromatoid BodyChromatinSystems BiologyEngineeringHuman Germ Cells	2011	44
Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours J. PLISIECKA-HA ASA, Agnieszka Dansonka‐Mieszkowska, Alina Rembiszewska, Annals of Human Genetics Nibrin ExpressionSomatic VariantTumor HeterogeneityNbs1 Gene AlterationsGenetics	2002	31
Nijmegen breakage syndrome gene (<i>NBS1</i>) alterations and its protein (nibrin) expression in human ovarian tumours Joanna Plisiecka-Hałasa, Agnieszka Dansonka‐Mieszkowska, Alina Rembiszewska, Annals of Human Genetics Tumoral PathologyNibrin ExpressionNbs1 Gene AlterationsGeneticsMedicine	2002	24
TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens Izabela Ziółkowska-Seta, Radosław Mądry, Ewa Kraszewska, Gynecologic Oncology Bax AnalysisTaxane-platinum RegimensMedicineMetronomic TherapyGynecology	2008	22

Page 1